Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos' two internally-developed cancer-screening tests, TMB-1 and TMB-2, have received a CE mark in Europe. Todos recently acquired U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab currently performing PCR COVID testing and Provista's proprietary commercial-stage Videssa® breast cancer blood test. Todos is also developing blood tests for the early detection of neurodegenerative disorders, such as Alzheimer's disease. The Lymphocyte Proliferation Test (LymPro Test™) is a diagnostic blood test that determines the ability of peripheral blood lymphocytes (PBLs) and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle. It is believed that certain diseases, most notably Alzheimer's disease, are the result of compromised cellular machinery that leads to aberrant cell cycle re-entry by neurons, which then leads to apoptosis. LymPro is unique in the use of peripheral blood lymphocytes as a surrogate for neuronal cell function, suggesting a common relationship between PBLs and neurons in the brain. Todos has entered into distribution agreements with companies to distribute certain novel coronavirus (COVID-19) test kits. The agreements cover multiple international suppliers of PCR testing kits and related materials and supplies, as well as antibody testing kits from multiple manufacturers after completing validation of said testing kits and supplies.
View Top Employees from Todos Medical (OTCQB: TOMDF)Website | http://www.todosmedical.com |
Ticker | TOMDF |
Revenue | $1 million |
Employees | 8 (8 on RocketReach) |
Founded | 2010 |
Address | 40 Wall Street Suite 2702, New York, New York 10005, US |
Phone | +972 54-638-0666 |
Technologies |
JavaScript,
HTML,
Twitter
+26 more
(view full list)
|
Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Laboratory Services (Healthcare), Healthcare, Biotechnology |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 325413 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Todos Medical (OTCQB: TOMDF) employee's phone or email?
The Todos Medical (OTCQB: TOMDF) annual revenue was $1 million in 2024.
Andrew Blumenthal is the Vice President Clinical Laboratory Services and Business Development of Todos Medical (OTCQB: TOMDF).
8 people are employed at Todos Medical (OTCQB: TOMDF).
Todos Medical (OTCQB: TOMDF) is based in New York, New York.
The NAICS codes for Todos Medical (OTCQB: TOMDF) are [325, 325413, 32, 3254, 32541].
The SIC codes for Todos Medical (OTCQB: TOMDF) are [283, 28].